2002
DOI: 10.1046/j.1474-9728.2002.00008.x
|View full text |Cite
|
Sign up to set email alerts
|

The role of chondrocyte senescence in osteoarthritis

Abstract: SummaryReplicative senescence occurs when normal somatic cells stop dividing. Senescent cells remain viable, but show alterations in phenotype, e.g. altered expression of matrix metalloproteinases ( MMPs ); these enzymes are known to be involved in cartilage destruction. It is assumed that cells deplete their replicative potential during aging, and age is a major risk factor for osteoarthritis (OA). Therefore, we hypothesized that chondrocytes in aging or diseased cartilage become senescent with associated phe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

7
226
0
4

Year Published

2002
2002
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 317 publications
(250 citation statements)
references
References 29 publications
7
226
0
4
Order By: Relevance
“…Chondrocyte proliferation can occur during the development of osteoarthritis (OA) in the form of cell clusters, but it is not known if this replicative response is regenerative, pathologic, or epiphenomenal (Lotz et al., 2010). Chondrocytes also display features of senescence with aging and OA, likely in response to macromolecular damage that accumulates in these long‐lived cells (Martin & Buckwalter, 2001; McCulloch, Litherland & Rai, 2017; Price et al., 2002; Rose et al., 2012). OA progression is driven by inflammatory cytokines that initiate a cascade of matrix degradation, and the prominent role for SASP factors such as matrix metalloproteinase 13 (MMP‐13) and interleukin 1 alpha (IL‐1α) implicates senescent cells in the joint as a source of these catabolic molecules (Loeser, Collins & Diekman, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Chondrocyte proliferation can occur during the development of osteoarthritis (OA) in the form of cell clusters, but it is not known if this replicative response is regenerative, pathologic, or epiphenomenal (Lotz et al., 2010). Chondrocytes also display features of senescence with aging and OA, likely in response to macromolecular damage that accumulates in these long‐lived cells (Martin & Buckwalter, 2001; McCulloch, Litherland & Rai, 2017; Price et al., 2002; Rose et al., 2012). OA progression is driven by inflammatory cytokines that initiate a cascade of matrix degradation, and the prominent role for SASP factors such as matrix metalloproteinase 13 (MMP‐13) and interleukin 1 alpha (IL‐1α) implicates senescent cells in the joint as a source of these catabolic molecules (Loeser, Collins & Diekman, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…SA ␤-gal activity has been recognized to be an important biologic marker of cell senescence (41), and it is higher in cloned chondrocytes in OA cartilage (23,32). Oxidized LDL increased the number of SA ␤-gal-positive BACs in a dosedependent manner, but native LDL had no effect.…”
Section: Zushi Et Almentioning
confidence: 98%
“…Telomere shortening has been demonstrated in OA chondrocytes (23,31,32), and the lifespan of senescent chondrocytes retrieved from OA cartilage can be increased by the exogenous expression of telomerase (33), indicating an important relationship between chondrocyte senescence and telomerase activity. In addition to replicative senescence, stressinduced premature cell senescence (SIPS) also occurs; in SIPS, cells without discernible attrition of telomeres show a growth arrest (34,35).…”
Section: Zushi Et Almentioning
confidence: 99%
See 2 more Smart Citations